Since its creation, Medisur has established itself as a key player in preventive health care in France. This innovative laboratory offers a wide range ofsaliva and urine self-tests, enabling everyone to monitor their health easily, directly from home. Whether it's to detect allergies, trace element deficiencies, organ dysfunctions or early cancer screening, Medisur devices are designed to provide a fast, reliable response to everyday health needs.
The traditional steps involved in obtaining a medical diagnosis can be complex and discouraging: making an appointment, travelling to the doctor and laboratory, waiting times... These are all steps that often slow patients down. According to statistics, two out of three French people have already foregone medical treatment, whether for lack of time, because of delays in obtaining an appointment, or because of the associated costs. Medisur has come up with a solution to this problem: simple, accessible self-tests that can be used at home, enabling people to take prompt action to look after themselves.
However, it is essential to remember that these self-tests do not replace a medical diagnosis. Their purpose is to act as an "alarm bell", directing the user to a medical consultation or further tests if necessary. In this way, Medisur acts as a partner to healthcare professionals, offering preventive solutions as part of a comprehensive approach to care. At Medisur, we firmly believe that your health belongs to you, and we help you preserve it with modern, high-performance tools.
Founded in 2015 by Vincent Dailloux and Édouard Rauline, Medisur was born of a clear ambition: to make preventive health care more accessible. From the outset, the company has specialized in health self-tests, meeting a variety of needs such as the detection of chronic diseases, fertility or even psychotropic drugs. In 2016, 12 self-tests were already distributed in pharmacies, enabling the general public to benefit from reliable solutions for monitoring their state of health.
The year 2020 marked a decisive milestone for Medisur. Faced with the global health crisis, the brand reoriented its business to respond to the urgent need to develop and distribute screening devices for the SARS-CoV-2 virus. Millions of tests were sold in France and abroad, confirming Medisur's expertise in designing medical solutions to meet pressing needs.
In 2022, Medisur broadened its scope of action by integrating occupational health prevention into its activities. Convinced that companies are ideal places to raise awareness and take action on individual well-being, the brand has supported over 300 companies in their Quality of Life at Work (QWL) initiatives. Whether through prevention plans, awareness-raising tools or concrete actions, Medisur puts its expertise at the service of employee health.
Medisur's values guide its day-to-day action:
In 2022, Medisur will have :
In 2023, Medisur obtained QUALIOPI certification, reinforcing its position as a trusted player in the preventive health sector. This distinction testifies to its commitment to the quality of its services and its constant concern to meet its customers' expectations.
Thanks to its solid expertise, remarkable capacity for innovation and commitment to accessibility, Medisur has become a benchmark in preventive healthcare. By making health proactive and accessible, Medisur invites everyone to take charge of their own well-being. With Medisur, take care of yourself, simply and effectively.
Medisur offers a wide selection of self-tests, covering a variety of themes to address your specific concerns. Each device is designed to be easy to use, accurate and reliable, while guaranteeing maximum autonomy.
These medical devices enable everyone to take independent action to improve their health. In case of doubt, healthcare professionals are on hand to interpret the results and suggest appropriate treatment.
